In Brief: Conceptus
This article was originally published in The Gray Sheet
Executive Summary
Conceptus: ERA resectoscope sheath gets marketing go ahead from FDA for use in gynecological applications including endometrial resection and ablation, myomectomy (fibroid removal) and polypectomy. The single-use device is intended for use with existing electrosurgical systems "to enhance the safety of therapeutic hysteroscopy procedures," Conceptus states. Company President and CEO Kathryn Tunstall commented: "By enhancing the safety of therapeutic hysteroscopy procedures, and making the procedures less costly and less burdensome for the OR staff, we believe that ERA will encourage the adoption of therapeutic hysteroscopy as a viable, minimally invasive alternative" to hysterectomy...